InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,457.26
(
0.47%
)
US TECH 100
19,268.40
(
0.53%
)
Dow Jones
38,687.51
(
0.25%
)
Brent Oil
83.31
(
1.44%
)
Bitcoin
65,945.84
(
-1.06%
)
Post# of 54032
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

2bStealthy

Send PM Follow Ignore
Followers 0
Posts 1996
Boards Moderated 0
Alias Born 07/04/2003

2bStealthy

Re: None

Tuesday, 04/08/2014 9:53:58 AM

Tuesday, April 08, 2014 9:53:58 AM

Post# of 54032
Cannabinoid CB2 receptor (CNR2)
In vitro and mouse studies suggest a CNR2-specific ligand–based photosensitizer could be useful for photodynamic cancer therapy. Further details on the research, next steps and licensing status are discussed in the article.

http://www.nature.com/scibx/journal/v7/n13/full/scibx.2014.368.html



Do not rely upon information I provide to make investment decisions.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up